Seniors with DLBCL may benefit from Ga101-miniCHOP combo
The combination obinutuzumab (Ga101) with the attenuated CHOP regimen (cyclophosphamide, doxorubicin, vincristine and prednisone; miniCHOP) is safe and effective for elderly patients with diffuse large B-cell lymphoma (DLBCL) who are unfit to receive the full-dose immunochemotherapy, a new study has found. However, the new regimen does not seem to be posed to challenge current treatment standards.